Author

N. Ruetalo

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Biochemistry· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 3 Organism:human· 2 Assay:proteomics· 2 Research Focus:dimensionality reduction· 1 Organism:mouse· 1 Organism:virus· 1 Organism:zebrafish· 1

Frequent Co-Authors

M. Schindler· 4 shared B. Traenkle· 2 shared D. Junker· 2 shared M. Becker· 2 shared N. Schneiderhan-Marra· 2 shared P. D. Kaiser· 2 shared R. Businger· 2 shared T. R. Wagner· 2 shared

Activity by Year

2019-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersMicrobiology

M. Schindler

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

A broadly neutralizing biparatopic Nanobody protects mice from lethal challenge with SARS-CoV-2 variants of concern

T. R. Wagner, D. Schnepf, J. Beer, K. Klingel, N. Ruetalo, P. D. Kaiser, D. Junker, M. Sauter, B. Traenkle, D. I. Frecot, M. Becker, N. Schneiderhan-Marra, A. Ohnemus, M. Schwemmle, M. Schindler, U. Rothbauer

This study identifies a biparatopic nanobody that protects mice from lethal SARS-CoV-2 infection and reduces viral load and inflammation.

bioRxiv · Aug 8, 2021 · PreprintBiochemistry

Rapid, dose-dependent and efficient inactivation of surface dried SARS-CoV-2 by 254 nm UV-C irradiation

N. Ruetalo, R. Businger, M. Schindler

This study evaluates the effectiveness of 254 nm UV-C irradiation in inactivating surface-dried SARS-CoV-2, showing dose-dependent inactivation and a non-linear relationship between UV-C dose and viral titer reduction.

bioRxiv · Sep 22, 2020Microbiology

NeutrobodyPlex - Nanobodies to monitor a SARS-CoV-2 neutralizing immune response

T. R. Wagner, P. D. Kaiser, M. Gramlich, E. Ostertag, N. Ruetalo, D. Junker, J. Haering, B. Traenkle, M. Becker, A. Dulovic, H. Schweizer, S. Nueske, A. Scholz, A. Zeck, K. Schenke-Layland, , U. Rothbauer

The paper develops NeutrobodyPlex, a multiplex assay using bivalent nanobodies to analyze neutralizing antibodies against SARS-CoV-2 in patient sera.

bioRxiv · Sep 22, 2020 · PreprintImmunology

The human α-defensin-derived peptide HD5(1-9) inhibits cellular attachment and entry of human cytomegalovirus.

R. Böffert, R. Businger, H. Preiss, D. Ehmann, V. Truffault, C. Simon, N. Ruetalo, K. Hamprecht, P. Müller, J. Wehkamp, M. Schindler

The paper identifies HD5(1-9), a defensin-derived peptide, as an inhibitor of HCMV cellular attachment and entry, with low toxicity.

bioRxiv · Nov 5, 2019Microbiology